ATG5 and metabolic dysfunction-associated steatohepatitis: To test the prediction that the protection from NASH conferred by LDTS-eLIR requires the autophagy machinery, the hepatoprotective effect of LDTS-eLIR was assessed in autophagy-deficient settings of liver-specific Atg5 knockout mice or chloroquine (CQ)-treated mice.